期刊文献+

起搏器术后上肢深静脉血栓形成的危险因素及其防治的临床证据 被引量:3

Deep Venous Thrombosis of Upper Extremities After Implantation of Cardiac Pacemaker:Analysis of the Risk Factors, Treatment and Secondary Prevention
下载PDF
导出
摘要 少有文献报道心脏起搏器植入术后可能发生深静脉血栓 (deepvenousthrombosis ,DVT) ,但DVT会严重影响病人的预后和生活质量 ,并可导致更为致命的肺动脉栓塞。DVT的危险因素、治疗策略和二级预防 ,各研究不尽相同。我们检索了CochraneLibrary ,PubMed和Guideline网站上有关DVT的系统评价和随机对照试验。证据显示 ,既往有DVT史、年龄 >4 0岁和有手术史是DVT的重要危险因素。肝素初始化治疗和华法令在维持期的治疗是必须和有效的 ,可改善病人的预后。对于发生过DVT的病人 ,在未来的高危状态下 ,可用肝素和 (或 ) Little has been reported about deep venous thrombosis(DVT) that occurs after the implantation of the cardiac pacemaker. DVT affects the prognosis and quality of life of patients severely, or even causes fatal pulmonary embolism. Research on its risk factors, therapeutic strategy and secondary prevention does not coincide with one another. We have searched the systematic reviews and randomized controlled trials of DVT through PubMed, Cochrane Library and Guideline. Evidence has showed that previous DVT, over 40 years of age, and surgical history are the major risk factors. Initial treatment of DVT with heparin and maintenance therapy with oral anticoagulant are indispensable and effective, and could improve the prognosis of patients. If patients with previous DVT are at increased risk in the future, heparin and / or oral anticoagulant application may be used for prophylaxis.
出处 《中国循证医学杂志》 CSCD 2004年第9期652-656,共5页 Chinese Journal of Evidence-based Medicine
关键词 术后并发症 上肢深静脉血栓形成 危险因素 预防 治疗 心脏起搏器植入术 Deep venous thrombosis Risk factors Evidence-based treatment Secondary prevention
  • 引文网络
  • 相关文献

参考文献25

  • 1Hirsh J, Fuster V, Ansell J, Halperin JL; American Heart As-sociation; American College of Cardiology Foundation. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy[J]. Circulation, 2003; 107(12): 1 692-1 711 被引量:1
  • 2Hull RD, Delmore T, Carter C, Hirsh J, Genton E, Gent M, Turpie G, McLaughlin D. Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis[J]. N Engl J Med, 1982; 306(4): 189-194 被引量:1
  • 3Pinede L, Duhaut P, Cucherat M, Ninet J, Pasquier J, Boissel JP. Comparison of long versus short duration of anticoagulant therapy after a first episode of venous thromboembolism: a meta-analysis of randomized, controlled trials[J]. Journal of Internal Me 被引量:1
  • 4Schulman S, Granqvist S, Holmstrom M, Carlsson A, Lindmarker P, Nicol P, Eklund SG, Nordlander S, Larfars G, Leijd B, Linder O, Loogna E. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism: Duration of Anticoagulat 被引量:1
  • 5Meyer G, Marjanovic Z, Valcke J, Lorcerie B, Gruel Y, Solal-Celigny P, Le Maignan C, Extra JM, Cottu P, Farge D. Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a rand 被引量:1
  • 6Brandjes DP, Heijboer H, Buller HR, de Rijk M, Jagt H, ten Cate JW. Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis[J]. N Engl J Med, 1992; 327(21): 1 485-1 489 被引量:1
  • 7Mohiuddin SM, Hilleman DE, Destache CJ, Stoysich AM, Gannon JM, Sketch MH Sr. Efficacy and safety of early versus late initiation of warfarin during heparin therapy in acute thromboembolism[J]. Am Heart J, 1992; 123(3): 729-732 被引量:1
  • 8Schulma S, Svenungsson E, Granqvist S. Anticardiolipin antibodies predict early recurrence of thromboembolism following anticoagulant therapy: Duration of Anticoagulation Study Group[J]. Am J Med, 1998; 104(4): 332-338 被引量:1
  • 9Hansson PO, Eriksson H, Welin L, Svardsudd K, Wilhelmsen L. Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: ""the study of men born in 1913""[J]. Arch Intern Med, 1999; 159(16): 1 886-1 890 被引量:1
  • 10Van den Belt AGM, Prins MH, Lensing AWA, Castro AA, Clark OAC, Atallah AN, Burihan E. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism (Cochrane Review) [M/CD]. In: The Cochrane L 被引量:1

同被引文献41

  • 1袁训芝,吴新民,袁家颖,宋琳琳.压力梯度长袜和间歇充气装置预防恶性肿瘤患者术后下肢深静脉血栓形成的效果[J].中华麻醉学杂志,2006,26(2):103-106. 被引量:40
  • 2李兰芝,尹少海.截瘫患者下肢深静脉血栓形成的护理干预[J].齐鲁护理杂志,2006,12(07B):1343-1344. 被引量:4
  • 3Rozmus G,Daubert JP, Huang DT, et al. Venous thrombosis and stenosis after implantation of pacemakers and defibrillators. J Interv Card Electrophysiol, 2005,13 ( 1 ) :9-19. 被引量:1
  • 4Scottish Intercollegiate Guidelines Network ( SIGN ). Prophylaxis of venous thromboembolisml A national clinical guideline. Edinburgh (Scotland) :Scottish Intercollegiate Guidelines Network (SIGN) ;2002.47. 被引量:1
  • 5Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest, 2001,119 ( 1 Suppl) :152S-175S. 被引量:1
  • 6Stein PD, Patel KC, Kalra NK, et al. Deep venous thrombosis in a general hospital. Chest, 2002,22 ( 3 ) : 960-962. 被引量:1
  • 7Practice parameters f or the prevention of venous thromboembolism. The Standards Task Force of the American Society of Colon and Rectal Surgeons. Dis Colon Rectum,2000,43 (8) :1037-1047. 被引量:1
  • 8Hansson PO, Eriksson H, Wetin L,et al. Smoking and abdominal obesity: risk factors for venous thro~mbo]ism among middle- aged men:"the study of men born in 1913". Arch Intern Med, 1999,159(16) :1886-1890. 被引量:1
  • 9Kearon C. Natural History of Veuou Thromboembolism. Circulation, 2003,107 (23suppl) :122-130. 被引量:1
  • 10Piazza G, Seddighzadeh A, Goldhaber SZ. Hearl failure in patients witth deep vein thrombosis. Am J Cardiol,2008,101 (7) : 1056-1059. 被引量:1

引证文献3

二级引证文献15

;
使用帮助 返回顶部